EAM Investors’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-204,994
| Closed | -$1.13M | – | 319 |
|
|
2023
Q2 | $1.13M | Sell |
204,994
-140,552
| -41% | -$772K | 0.21% | 219 |
|
|
2023
Q1 | $1.45M | Buy |
+345,546
| New | +$1.45M | 0.29% | 180 |
|
|
2021
Q4 | – | Sell |
-170,580
| Closed | -$1.19M | – | 319 |
|
|
2021
Q3 | $1.19M | Sell |
170,580
-36,409
| -18% | -$254K | 0.2% | 242 |
|
|
2021
Q2 | $1.72M | Hold |
206,989
| – | – | 0.27% | 166 |
|
|
2021
Q1 | $1.13M | Buy |
+206,989
| New | +$1.13M | 0.17% | 287 |
|
|
2018
Q4 | – | Sell |
-266,078
| Closed | -$1.4M | – | 276 |
|
|
2018
Q3 | $1.4M | Buy |
266,078
+154,004
| +137% | +$809K | 0.21% | 172 |
|
|
2018
Q2 | $600K | Sell |
112,074
-20,462
| -15% | -$110K | 0.09% | 272 |
|
|
2018
Q1 | $663K | Buy |
+132,536
| New | +$663K | 0.11% | 246 |
|
|
2015
Q2 | – | Sell |
-269,442
| Closed | -$1.57M | – | 343 |
|
|
2015
Q1 | $1.57M | Buy |
+269,442
| New | +$1.57M | 0.18% | 225 |
|